Yuag, Qiana Mae .

HRN: 29-27-82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/08/2026
07/14/2026
IV
48mg
Q24
MAP
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines